| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
LIVER AND BILIARY TRACT
Departments of 1Physiology and Pharmacology and 2Pathobiology, Texas A&M University, College Station, Texas
Submitted 11 November 2004 ; accepted in final form 23 August 2005
Although liver fatty acid binding protein (L-FABP) is postulated to influence cholesterol homeostasis, the physiological significance of this hypothesis remains to be resolved. This issue was addressed by examining the response of young (7 wk) female mice to L-FABP gene ablation and a cholesterol-rich diet. In control-fed mice, L-FABP gene ablation alone induced hepatic cholesterol accumulation (2.6-fold), increased bile acid levels, and increased body weight gain (primarily as fat tissue mass). In cholesterol-fed mice, L-FABP gene ablation further enhanced the hepatic accumulation of cholesterol (especially cholesterol ester, 12-fold) and potentiated the effects of dietary cholesterol on increased body weight gain, again mainly as fat tissue mass. However, in contrast to the effects of L-FABP gene ablation in control-fed mice, biliary levels of bile acids (as well as cholesterol and phospholipids) were reduced. These phenotypic alterations were not associated with differences in food intake. In conclusion, it was shown for the first time that L-FABP altered cholesterol metabolism and the response of female mice to dietary cholesterol. While the biliary and lipid phenotype of female wild-type L-FABP+/+ mice was sensitive to dietary cholesterol, L-FABP gene ablation dramatically enhanced many of the effects of dietary cholesterol to greatly induce hepatic cholesterol (primarily cholesterol ester) and triacylglycerol accumulation as well as to potentiate body weight gain (primarily as fat tissue mass). Taken together, these data support the hypothesis that L-FABP is involved in the physiological regulation of cholesterol metabolism, body weight gain, and obesity.
cholesterol ester; triacylglycerol; mouse
This article has been cited by other articles:
|
|
 |
|
  B. P. Atshaves, A. L. McIntosh, G. G. Martin, D. Landrock, H. R. Payne, S. Bhuvanendran, K. K. Landrock, O. I. Lyuksyutova, J. D. Johnson, R. D. Macfarlane, et al. Overexpression of sterol carrier protein-2 differentially alters hepatic cholesterol accumulation in cholesterol-fed mice J. Lipid Res., July 1, 2009; 50(7): 1429 - 1447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xie, E. P. Newberry, S. M. Kennedy, J. Luo, and N. O. Davidson Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice J. Lipid Res., May 1, 2009; 50(5): 977 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Martin, B. P. Atshaves, A. L. McIntosh, J. T. Mackie, A. B. Kier, and F. Schroeder Liver Fatty Acid-Binding Protein Gene-Ablated Female Mice Exhibit Increased Age-Dependent Obesity J. Nutr., October 1, 2008; 138(10): 1859 - 1865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Newberry, S. M. Kennedy, Y. Xie, B. T. Sternard, J. Luo, and N. O. Davidson Diet-induced obesity and hepatic steatosis in L-Fabp / mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G307 - G314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Wang, H. Li, N. Li, L. Leng, and Y. Wang Tissue expression and association with fatness traits of liver Fatty Acid-binding protein gene in chicken. Poult. Sci., November 1, 2006; 85(11): 1890 - 1895. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
